Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul Edward Sax, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. M01RR002635 (GOTTLIEB, GARY L) Dec 1, 1984 - Mar 31, 2010
    NIH
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ganatra S, Dani SS, Sax PE. Reply to Authors. Clin Infect Dis. 2023 Feb 18; 76(4):774-775. PMID: 36111436.
    Citations: 1     Fields:    
  2. Ganatra S, Dani SS, Ahmad J, Kumar A, Shah J, Abraham GM, McQuillen DP, Wachter RM, Sax PE. Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019. Clin Infect Dis. 2023 02 18; 76(4):563-572. PMID: 35986628; PMCID: PMC9452095.
    Citations: 18     Fields:    Translation:Humans
  3. Bares SH, Marcelin JR, Blumenthal J, Sax PE. Call to Action: Prioritizing the Use of Inclusive, Non-stigmatizing Language in Scientific Communications. Clin Infect Dis. 2023 Jan 31. PMID: 36718982.
    Citations:    Fields:    
  4. Barnett ML, Sax PE. Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited. JAMA. 2023 01 03; 329(1):25-27. PMID: 36525259.
    Citations:    Fields:    Translation:HumansCells
  5. Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, Springer SA, Sax PE, Thompson MA, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Günthard HF, Molina JM, Jacobsen DM, Saag MS. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2023 01 03; 329(1):63-84. PMID: 36454551.
    Citations: 2     Fields:    Translation:HumansCells
  6. Gibas KM, Kelly SG, Arribas JR, Cahn P, Orkin C, Daar ES, Sax PE, Taiwo BO. Two-drug regimens for HIV treatment. Lancet HIV. 2022 12; 9(12):e868-e883. PMID: 36309038; PMCID: PMC10015554.
    Citations: 1     Fields:    Translation:HumansCells
  7. Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, Martin DT, Sax PE, Dani SS, Ganatra S. Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 11 15; 80(20):1912-1924. PMID: 36243540; PMCID: PMC9580069.
    Citations:    Fields:    Translation:HumansPHPublic Health
  8. Sax PE. "Never Once Have I Ever Been Bored"-Exciting Times Ahead for Clinical Infectious Diseases. Clin Infect Dis. 2022 08 24; 75(1):1-2. PMID: 36008928.
    Citations:    Fields:    Translation:Humans
  9. Mozaffari E, Chandak A, Zhang Z, Liang S, Thrun M, Gottlieb RL, Kuritzkes DR, Sax PE, Wohl DA, Casciano R, Hodgkins P, Haubrich R. Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort. Clin Infect Dis. 2022 08 24; 75(1):e450-e458. PMID: 34596223; PMCID: PMC9402660.
    Citations: 30     Fields:    Translation:HumansCells
  10. Sax PE. Rosa. JAMA. 2022 08 16; 328(7):621. PMID: 35972482.
    Citations:    Fields:    Translation:Animals
  11. Jhaveri TA, Harris C, Sax PE. IgM Positivity for Both EBV and CMV: A Clinical Conundrum. Open Forum Infect Dis. 2022 Jul; 9(7):ofac316. PMID: 35873288; PMCID: PMC9297312.
    Citations:    
  12. Sax PE, Andreatta K, Molina JM, Daar ES, Hagins D, Acosta R, D'Antoni ML, Chang S, Martin R, Liu H, Blair C, McNicholl I, Gallant J, Collins SE, Martin H, White KL. High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I. AIDS. 2022 09 01; 36(11):1511-1520. PMID: 35466963; PMCID: PMC9451915.
    Citations:    Fields:    Translation:HumansCells
  13. Nagami EH, Thakarar K, Sax PE. Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance. Open Forum Infect Dis. 2022 Feb; 9(2):ofab648. PMID: 35111871; PMCID: PMC8802795.
    Citations: 1     
  14. Erlandson KM, Carter CC, Melbourne K, Brown TT, Cohen C, Das M, Esser S, Huang H, Koethe JR, Martin H, McComsey GA, Orkin C, Post FA, Rockstroh JK, Sax PE, Stellbrink HJ, Waters L, Wei X, Lake JE. Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials. Clin Infect Dis. 2021 10 20; 73(8):1440-1451. PMID: 33987636.
    Citations: 10     Fields:    Translation:Humans
  15. Llibre JM, Sax PE. Reassessing oral lead-in for injectable long-acting HIV therapy. Lancet HIV. 2021 11; 8(11):e660-e661. PMID: 34656209.
    Citations:    Fields:    Translation:Humans
  16. Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, Llibre JM, Camazine M, Díaz-De Santiago A, Carlucci PM, Zacharioudakis IM, Rahimian J, Wanjalla CN, Slim J, Arinze F, Kratz AMP, Jones JL, Patel SM, Kitchell E, Francis A, Ray M, Koren DE, Baddley JW, Hill B, Sax PE, Chow J. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019. Clin Infect Dis. 2021 10 05; 73(7):e1964-e1972. PMID: 32905581.
    Citations: 67     Fields:    Translation:HumansCells
  17. Mozaffari E, Chandak A, Zhang Z, Liang S, Gayle J, Thrun M, Gottlieb RL, Kuritzkes DR, Sax PE, Wohl DA, Casciano R, Hodgkins P, Haubrich R. Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States. Open Forum Infect Dis. 2022 Jan; 9(1):ofab498. PMID: 34984212; PMCID: PMC8522394.
    Citations: 1     
  18. Sax PE, Rockstroh JK, Luetkemeyer AF, Yazdanpanah Y, Ward D, Trottier B, Rieger A, Liu H, Acosta R, Collins SE, Brainard DM, Martin H. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus. Clin Infect Dis. 2021 07 15; 73(2):e485-e493. PMID: 32668455.
    Citations: 16     Fields:    Translation:HumansCells
  19. Orkin C, Squires KE, Molina JM, Sax PE, Sussmann O, Lin G, Kumar S, Hanna GJ, Hwang C, Martin E, Teppler H. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial. Clin Infect Dis. 2021 07 01; 73(1):33-42. PMID: 33336698; PMCID: PMC8246893.
    Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
  20. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2. Ann Intern Med. 2021 07; 174(7):1037. PMID: 34280346.
    Citations: 3     Fields:    Translation:HumansCells
  21. Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K, Coletti A, Jean-Philippe P, Johnston B, Krotje C, Fairlie L, Hoffman RM, Sax PE, Moyo S, Chakhtoura N, Stringer JS, Masheto G, Korutaro V, Cassim H, Mmbaga BT, João E, Hanley S, Purdue L, Holmes LB, Momper JD, Shapiro RL, Thoofer NK, Rooney JF, Frenkel LM, Amico KR, Chinula L, Currier J. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021 04 03; 397(10281):1276-1292. PMID: 33812487; PMCID: PMC8132194.
    Citations: 24     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  22. Paltiel AD, Zheng A, Sax PE. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. Ann Intern Med. 2021 06; 174(6):803-810. PMID: 33683930; PMCID: PMC9317280.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  23. Saag MS, Gandhi RT, Sax PE. Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply. JAMA. 2021 03 02; 325(9):889-890. PMID: 33651088.
    Citations:    Fields:    Translation:Humans
  24. Paltiel AD, Zheng A, Sax PE. Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. medRxiv. 2021 Feb 08. PMID: 33564779; PMCID: PMC7872371.
    Citations: 1     
  25. Cevik M, Haque SA, Manne-Goehler J, Kuppalli K, Sax PE, Majumder MS, Orkin C. Gender disparities in coronavirus disease 2019 clinical trial leadership. Clin Microbiol Infect. 2021 Jul; 27(7):1007-1010. PMID: 33418021.
    Citations: 9     Fields:    Translation:Humans
  26. Curtis MR, Sax P. Web Exclusive. Annals for Hospitalists Inpatient Notes - Remdesivir-Making Sense of Emerging Evidence. Ann Intern Med. 2020 Dec 15; 173(12):HO2-HO3. PMID: 33316192.
    Citations:    Fields:    
  27. Jilg N, Garcia-Broncano P, Peluso M, Segal FP, Bosch RJ, Roberts-Toler C, Chen SMY, Van Dam CN, Keefer MC, Kuritzkes DR, Landay AL, Deeks S, Yu XG, Sax PE, Li JZ. Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy. J Infect Dis. 2020 11 09; 222(11):1837-1842. PMID: 32496516; PMCID: PMC7896274.
    Citations: 1     Fields:    Translation:HumansCells
  28. Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020 10 27; 324(16):1651-1669. PMID: 33052386.
    Citations: 125     Fields:    Translation:HumansCellsPHPublic Health
  29. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med. 2021 01; 174(1):69-79. PMID: 32941052; PMCID: PMC7505025.
    Citations: 294     Fields:    Translation:HumansCellsPHPublic Health
  30. Sax PE, Erlandson KM, Lake JE, Mccomsey GA, Orkin C, Esser S, Brown T